Badanie długoterminowych wyników leczenia retinopatii wcześniaków z użyciem afliberceptu

Retinopathy of prematurity is a condition that affects the eyes of premature babies, potentially leading to vision problems. This study focuses on understanding the long-term effects of a treatment used in a previous study for this condition. The treatment involves a medication called aflibercept, which is administered as a solution for injection. The purpose of this study is to evaluate the long-term safety and visual function of children who received this treatment.

The study will follow participants over several years to monitor their vision and overall eye health. It will assess various aspects such as visual acuity, which is the clarity or sharpness of vision, and any potential eye-related issues that may arise. Additionally, the study will look at the overall development of the children, including their neurodevelopmental progress, which refers to the development of the brain and nervous system.

Participants in this study are those who were previously treated in an earlier study. The study aims to gather information on how well the treatment works over time and to identify any long-term effects. This information will help in understanding the effectiveness and safety of aflibercept for treating retinopathy of prematurity in young children.